-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PrZ8l4XiXraWG2LqF9regVaUZOj+qbdYrFVG0eypb1vsE+lB2Tdvd0G0se77IyrY Shoey48o1CfsYypT2w5g0w== 0000895418-96-000001.txt : 19960222 0000895418-96-000001.hdr.sgml : 19960222 ACCESSION NUMBER: 0000895418-96-000001 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960221 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-10567 FILM NUMBER: 96523608 BUSINESS ADDRESS: STREET 1: 2700 COLORADO AVE CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: 3103158000 MAIL ADDRESS: STREET 1: P O BOX 4070 CITY: SANTA MONICA STATE: CA ZIP: 90404 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GKH INVESTMENTS L P CENTRAL INDEX KEY: 0000931449 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 363517804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 200 WEST MADISON STREET CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3127508477 MAIL ADDRESS: STREET 2: 200 WEST MADISON CITY: CHICAGO STATE: IL ZIP: 60606 SC 13D/A 1 SCHEDULE 13D AMENDMENT NO. 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Tenet Healthcare Corporation (formerly National Medical Enterprises, Inc.) (Name of Issuer) Common Stock, $0.075 par value per share (Title of Class of Securities) 88033G-10-0 (CUSIP Number) Harold S. Handelsman, Esq. 200 West Madison Street Chicago, Illinois 60606 (312) 750-8102 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 13, 1996 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Check the following box if a fee is being paid with the statement [ ]. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) NOTE: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder on this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (continued on following pages) Page 1 of 4 Pages 1. NAME OF REPORTING PERSON GKH Investments, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. SOURCE OF FUNDS OO (See Item 3) 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER 7. SOLE VOTING POWER OF -0- SHARES BENEFICIALLY 8. SHARED VOTING POWER OWNED BY -0- REPORTING 9. SOLE DISPOSITIVE POWER PERSON -0- WITH 10. SHARED DISPOSITIVE POWER -0- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON -0- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [X] The aggregate amount set forth in row 11 excludes 392,530 shares of Common Stock (.20% of the outstanding shares) owned by GKH Private Limited. See Items 3 and 6 of the initial Schedule 13D. 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% 14. TYPE OF REPORTING PERSON PN Page 2 of 4 pages ONLY THOSE ITEMS AMENDED ARE REPORTED HEREIN - -------------------------------------------- THIS AMENDMENT NO. 1 AMENDS THE INITIAL SCHEDULE 13D RELATING TO COMMON STOCK OF NATIONAL MEDICAL ENTERPRISES, INC., A NEVADA CORPORATION AND PREDECESSOR OF TENET HEALTHCARE CORPORATION, DATED MARCH 10, 1995 (THE "INITIAL SCHEDULE 13D"). CAPITALIZED TERMS NOT OTHERWISE DEFINED HEREIN SHALL HAVE THE MEANINGS ASCRIBED TO THEM IN THE INITIAL SCHEDULE 13D. Item 1. Security and Issuer ------------------- This Amendment No. 1 to Schedule 13D relates to the Common Stock, $0.075 par value per share (the "Common Stock"), of Tenet Healthcare Corporation (the "Company"), the principal executive offices of which are located at 2700 Colorado Avenue, Santa Monica, California 90404. Item 2. Interest in Securities of the Issuer ------------------------------------ (a) - (b) As of February 13, 1996, GKH, the General Partner of the Fund, determined it to be in the best interest of the limited partners of the Fund to distribute the 10,382,050 shares of Common Stock then held by the Fund to the partners of the Fund. Accordingly, as of such date, (i) each of the Fund's partners became the beneficial owner of their pro rata share of the Common Stock previously held by the Fund, and (ii) the Fund no longer beneficially owned shares of Common Stock or had any voting or dispositive power with respect thereto. No partner of the Fund received 5% or more of the Company's outstanding Common Stock as a result of the Fund's distribution. (c) Other than as described above, during the past 60 days, neither the Fund nor, to the best knowledge of the Fund, any of the persons identified in Appendix A to the initial Schedule 13D, have effected any other transactions in the Common Stock. (d) As of February 13, 1996, each of the Fund's partners became the beneficial owner of their pro rata share of the Common Stock previously held by the Fund. No partner of the Fund received 5% or more of the Company's outstanding Common Stock as a result of the Fund's distribution. (e) February 13, 1996. Page 3 of 4 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 20, 1996. GKH INVESTMENTS, L.P., a Delaware limited partnership By: GKH PARTNERS, L.P., its general partner By: HGM ASSOCIATES LIMITED PARTNERSHIP, a general partner By: HGM CORPORATION, its general partner By: ________________________________ Harold S. Handelsman, Vice President Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----